KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 112 filers reported holding KEROS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,645 | -27.9% | 2,561 | -9.1% | 0.05% | -25.4% |
| Q2 2023 | $113,227 | +31.5% | 2,818 | +39.7% | 0.07% | +42.6% |
| Q1 2023 | $86,126 | -35.7% | 2,017 | -27.7% | 0.05% | -32.9% |
| Q4 2022 | $133,880 | -7.0% | 2,788 | -27.1% | 0.07% | +22.8% |
| Q3 2022 | $144,000 | +37.1% | 3,825 | +0.8% | 0.06% | +46.2% |
| Q2 2022 | $105,000 | -40.0% | 3,793 | +17.6% | 0.04% | -50.0% |
| Q1 2022 | $175,000 | -12.5% | 3,225 | -5.6% | 0.08% | +2.6% |
| Q4 2021 | $200,000 | +25.8% | 3,416 | -14.9% | 0.08% | +8.6% |
| Q3 2021 | $159,000 | -11.7% | 4,016 | -5.0% | 0.07% | -5.4% |
| Q2 2021 | $180,000 | -23.7% | 4,229 | +10.3% | 0.07% | -26.0% |
| Q1 2021 | $236,000 | -10.9% | 3,835 | +2.0% | 0.10% | -9.1% |
| Q4 2020 | $265,000 | – | 3,758 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |